Lancet Poradnie Specjalistycznesp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-07-31
Share capital
100,000.00 PLN
Registered address
al. Wojska Polskiego 92, 70-481 Szczecin, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 88 days late).

  • 202530/05/2026
  • 202425/06/2025
  • 202311/07/2024
  • 202212/07/2023
  • 202111/10/2022
  • 202011/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.82mMedianUSD 443.50kAverageUSD 1.75m
Net profit
This companyUSD 443.72kMedianUSD 14.30kAverageUSD 129.62k
Operating costs
This companyUSD 1.33mMedianUSD 396.18kAverageUSD 1.56m
Assets
This companyUSD 718.11kMedianUSD 173.81kAverageUSD 1.02m

Industry

National Health Fund (NFZ) contracts

Lancet Poradnie Specjalistyczne has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 1.42m. All its contracts were worth USD 12.81m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Outpatient specialist carezachodniopomorskie1USD 1.42m

NFZ waiting lists

This company's facilities run 2 NFZ waiting lists. Waiting time forecast by NFZ, as of 14.10.2026.

ServiceWaiting time
Services in orthopedics and traumatology of the musculoskeletal system2 mo 1 wk
General surgery clinic2 mo 2 wk

Authorized Representatives

Maciej Andrzej Miernik – President of the Management Board
Artur Osadowski – Vice President of the Management Board

Manner of representation

The management board may be one-person or multi-member. In the case of a multi-member management board, each member of the management board is authorised to make declarations of will on behalf of the company independently, subject to the following: a) incurring obligations on behalf of the company or disposing of rights with a value exceeding 15,000 złoty (fifteen thousand złoty) requires the joint action of two members of the management board or a member of the management board jointly with a commercial proxy; b) in non-pecuniary matters, the joint action of two members of the management board or a member of the management board jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
Maciej Andrzej Miernikage 66
30$8,103.7330%
Ilona Osadowskaage 56
30$8,103.7330%
Artur Osadowskiage 57
10$2,701.2410%
Grażyna Maria Wielgoszewskaage 78
30$8,103.7330%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2008-11-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,266
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,567
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,379

Competitors

Name
Uromedsp. z o.o.
Oculus Małkowski I Wspólnicysp. k.
WN Medicasp. z o.o.
SCAN Medicasp. z o.o.
Miniklinikasp. z o.o.
Makmentissp. z o.o.
Abmed Expertssp. z o.o.
Largosp. z o.o.
DM Clinicsp. z o.o.
Zakład Opieki Zdrowotnej Lekarz Mizerskisp. j.

FAQ

Last updated: 2026-05-30